These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26227494)

  • 21. Endoscopic augmentation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease: multicenter study of the Gatekeeper Reflux Repair System.
    Fockens P; Bruno MJ; Gabbrielli A; Odegaard S; Hatlebakk J; Allescher HD; Rösch T; Rhodes M; Bastid C; Rey J; Boyer J; Muehldorffer S; van den Hombergh U; Costamagna G
    Endoscopy; 2004 Aug; 36(8):682-9. PubMed ID: 15280972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic full-thickness plication for the treatment of GERD by application of multiple Plicator implants: a multicenter study (with video).
    von Renteln D; Schiefke I; Fuchs KH; Raczynski S; Philipper M; Breithaupt W; Caca K; Neuhaus H
    Gastrointest Endosc; 2008 Nov; 68(5):833-44. PubMed ID: 18534586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)-a short-term study.
    Liu S; Chai N; Zhai Y; Zou J; Feng X; Li Z; Li L; Zhang X; Wang X; Wang S; Linghu EQ
    Surg Endosc; 2020 Oct; 34(10):4516-4524. PubMed ID: 31728750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution manometry of the EGJ: an analysis of crural diaphragm function in GERD.
    Pandolfino JE; Kim H; Ghosh SK; Clarke JO; Zhang Q; Kahrilas PJ
    Am J Gastroenterol; 2007 May; 102(5):1056-63. PubMed ID: 17319930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
    Takeuchi T; Hongo H; Kimura T; Kojima Y; Harada S; Ota K; Takeuchi N; Noguchi T; Inoue T; Murano M; Higuchi K
    J Gastroenterol; 2019 Nov; 54(11):972-983. PubMed ID: 31037449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: final results of open-label prospective trial.
    Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Saba J; Perez-Castilla A; Galvao Neto M; Crowell MD
    Surg Endosc; 2013 Apr; 27(4):1083-92. PubMed ID: 23073680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.
    Hatlebakk JG; Zerbib F; Bruley des Varannes S; Attwood SE; Ell C; Fiocca R; Galmiche JP; Eklund S; Långström G; Lind T; Lundell LR;
    Clin Gastroenterol Hepatol; 2016 May; 14(5):678-85.e3. PubMed ID: 26226096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoluminal gastroplication for the treatment of gastroesophageal reflux disease: a 2-year prospective pilot study from Taiwan.
    Liao CC; Lee CL; Lin BR; Bai CH; Hsieh YH; Wu CH; Gostout CJ
    J Gastroenterol Hepatol; 2008 Mar; 23(3):398-405. PubMed ID: 18318824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease.
    Lee J; Anggiansah A; Anggiansah R; Young A; Wong T; Fox M
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1392-8. PubMed ID: 17936081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Feeding Strategies With Acid Suppression on Esophageal Reflexes in Human Neonates With Gastroesophageal Reflux Disease: A Single-Blinded Randomized Clinical Trial.
    Jadcherla SR; Hasenstab KA; Gulati IK; Helmick R; Ipek H; Yildiz V; Wei L
    Clin Transl Gastroenterol; 2020 Nov; 11(11):e00249. PubMed ID: 33259163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD.
    Tolone S; de Cassan C; de Bortoli N; Roman S; Galeazzi F; Salvador R; Marabotto E; Furnari M; Zentilin P; Marchi S; Bardini R; Sturniolo GC; Savarino V; Savarino E
    Neurogastroenterol Motil; 2015 Aug; 27(8):1175-82. PubMed ID: 26010058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results.
    Rodríguez L; Rodriguez PA; Gómez B; Netto MG; Crowell MD; Soffer E
    Surg Endosc; 2016 Jul; 30(7):2666-72. PubMed ID: 26487200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
    Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Sakamoto H; Kuramoto T; Kojima K; Sanomura M; Hoshimoto M; Higashino T; Itabashi T; Takada K; Sakaguchi M; Tominaga K; Kusano M; Higuchi K
    J Gastroenterol Hepatol; 2018 Mar; 33(3):623-630. PubMed ID: 28865098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease.
    Rohof WO; Bennink RJ; de Jonge H; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1647-55. PubMed ID: 24184737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breathing training on lower esophageal sphincter as a complementary treatment of gastroesophageal reflux disease (GERD): a systematic review.
    Casale M; Sabatino L; Moffa A; Capuano F; Luccarelli V; Vitali M; Ribolsi M; Cicala M; Salvinelli F
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4547-4552. PubMed ID: 27874942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.
    Ashida K; Kinoshita Y; Hongo M;
    Dig Dis Sci; 2011 Aug; 56(8):2333-42. PubMed ID: 21302138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease.
    Ota K; Takeuchi T; Harada S; Edogawa S; Kojima Y; Inoue T; Higuchi K
    Scand J Gastroenterol; 2014 Dec; 49(12):1409-13. PubMed ID: 25384555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.